{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:25:47Z","timestamp":1790508347466,"version":"4.1.0"},"publisher-location":"Cham","reference-count":189,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319511511","type":"print"},{"value":"9783319511528","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/7854_2016_2","type":"book-chapter","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T22:13:15Z","timestamp":1464127995000},"page":"3-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Evidence for Inflammation-Associated Depression"],"prefix":"10.1007","author":[{"given":"Celina S.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Adibfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Lanct\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,25]]},"reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/bs.acc.2014.11.003","volume":"68","author":"TL Huang","year":"2015","unstructured":"Huang TL, Lin CC (2015) Advances in biomarkers of major depressive disorder. Adv Clin Chem 68:177\u2013204","journal-title":"Adv Clin Chem"},{"issue":"Suppl 1","key":"2_CR2","first-page":"3","volume":"7","author":"JP Lepine","year":"2011","unstructured":"Lepine JP, Briley M (2011) The increasing burden of depression. Neuropsychiatr Dis Treat 7(Suppl 1):3\u20137","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"2_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4088\/JCP.14m09298","volume":"76","author":"PE Greenberg","year":"2015","unstructured":"Greenberg PE et al (2015) The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry 76(2):155\u2013162","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"2_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1176\/ajp.156.6.837","volume":"156","author":"KS Kendler","year":"1999","unstructured":"Kendler KS, Karkowski LM, Prescott CA (1999) Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 156(6):837\u2013841","journal-title":"Am J Psychiatry"},{"issue":"6","key":"2_CR5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0006-3223(02)01405-1","volume":"52","author":"EJ Nestler","year":"2002","unstructured":"Nestler EJ et al (2002) Preclinical models: status of basic research in depression. Biol Psychiatry 52(6):503\u2013528","journal-title":"Biol Psychiatry"},{"issue":"4\u20135","key":"2_CR6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neubiorev.2005.03.011","volume":"29","author":"CR Pryce","year":"2005","unstructured":"Pryce CR et al (2005) Long-term effects of early-life environmental manipulations in rodents and primates: potential animal models in depression research. Neurosci Biobehav Rev 29(4\u20135):649\u2013674","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"2_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3109\/07853891003769957","volume":"42","author":"DD Pollak","year":"2010","unstructured":"Pollak DD, Rey CE, Monje FJ (2010) Rodent models in depression research: classical strategies and new directions. Ann Med 42(4):252\u2013264","journal-title":"Ann Med"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/7854_2010_108","volume":"7","author":"V Krishnan","year":"2011","unstructured":"Krishnan V, Nestler EJ (2011) Animal models of depression: molecular perspectives. Curr Top Behav Neurosci 7:121\u2013147","journal-title":"Curr Top Behav Neurosci"},{"issue":"1","key":"2_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00441-013-1664-0","volume":"354","author":"O Wiborg","year":"2013","unstructured":"Wiborg O (2013) Chronic mild stress for modeling anhedonia. Cell Tissue Res 354(1):155\u2013169","journal-title":"Cell Tissue Res"},{"issue":"1","key":"2_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00441-013-1692-9","volume":"354","author":"V Micale","year":"2013","unstructured":"Micale V, Kucerova J, Sulcova A (2013) Leading compounds for the validation of animal models of psychopathology. Cell Tissue Res 354(1):309\u2013330","journal-title":"Cell Tissue Res"},{"issue":"4","key":"2_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nn1659","volume":"9","author":"NM Tsankova","year":"2006","unstructured":"Tsankova NM et al (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9(4):519\u2013525","journal-title":"Nat Neurosci"},{"issue":"Suppl 1","key":"2_CR12","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1097\/01.psy.0000164013.55453.05","volume":"67","author":"TZ Naqvi","year":"2005","unstructured":"Naqvi TZ, Naqvi SS, Merz CN (2005) Gender differences in the link between depression and cardiovascular disease. Psychosom Med 67(Suppl 1):S15\u2013S18","journal-title":"Psychosom Med"},{"issue":"3","key":"2_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/ajmg.b.30824","volume":"150B","author":"JM McCaffery","year":"2009","unstructured":"McCaffery JM et al (2009) Genetic predictors of depressive symptoms in cardiac patients. Am J Med Genet B Neuropsychiatr Genet 150B(3):381\u2013388","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"2","key":"2_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1042\/cs1010185","volume":"101","author":"A Steptoe","year":"2001","unstructured":"Steptoe A et al (2001) Acute mental stress elicits delayed increases in circulating inflammatory cytokine levels. Clin Sci (Lond) 101(2):185\u2013192","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"2_CR15","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1164\/ajrccm.152.2.7633716","volume":"152","author":"JH Persoons","year":"1995","unstructured":"Persoons JH et al (1995) Acute stress affects cytokines and nitric oxide production by alveolar macrophages differently. Am J Respir Crit Care Med 152(2):619\u2013624","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2_CR16","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00213-004-2103-4","volume":"179","author":"AJ Grippo","year":"2005","unstructured":"Grippo AJ et al (2005) Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats. Psychopharmacology (Berl) 179(4):769\u2013780","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"2_CR17","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0192-0561(98)00050-2","volume":"20","author":"M Kubera","year":"1998","unstructured":"Kubera M et al (1998) Effect of mild chronic stress, as a model of depression, on the immunoreactivity of C57BL\/6 mice. Int J Immunopharmacol 20(12):781\u2013789","journal-title":"Int J Immunopharmacol"},{"issue":"7","key":"2_CR18","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/sj.mp.4002055","volume":"13","author":"I Goshen","year":"2008","unstructured":"Goshen I et al (2008) Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry 13(7):717\u2013728","journal-title":"Mol Psychiatry"},{"issue":"12","key":"2_CR19","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1248\/bpb.29.2399","volume":"29","author":"Y Pan","year":"2006","unstructured":"Pan Y et al (2006) Effects of icariin on hypothalamic-pituitary-adrenal axis action and cytokine levels in stressed Sprague\u2013Dawley rats. Biol Pharm Bull 29(12):2399\u20132403","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"2_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbr.2011.07.006","volume":"225","author":"Z You","year":"2011","unstructured":"You Z et al (2011) Pro- and anti-inflammatory cytokines expression in rat\u2019s brain and spleen exposed to chronic mild stress: involvement in depression. Behav Brain Res 225(1):135\u2013141","journal-title":"Behav Brain Res"},{"issue":"17\u201318","key":"2_CR21","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.lfs.2008.02.010","volume":"82","author":"S Li","year":"2008","unstructured":"Li S et al (2008) Chronic mild stress impairs cognition in mice: from brain homeostasis to behavior. Life Sci 82(17\u201318):934\u2013942","journal-title":"Life Sci"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bbr.2012.12.041","volume":"242","author":"W Liu","year":"2013","unstructured":"Liu W et al (2013) Swimming exercise ameliorates depression-like behavior in chronically stressed rats: relevant to proinflammatory cytokines and IDO activation. Behav Brain Res 242:110\u2013116","journal-title":"Behav Brain Res"},{"issue":"3","key":"2_CR23","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.nbd.2006.05.001","volume":"23","author":"S Chourbaji","year":"2006","unstructured":"Chourbaji S et al (2006) IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors. Neurobiol Dis 23(3):587\u2013594","journal-title":"Neurobiol Dis"},{"issue":"4","key":"2_CR24","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S0306-4530(02)00039-2","volume":"28","author":"A Bartolomucci","year":"2003","unstructured":"Bartolomucci A et al (2003) Individual housing induces altered immuno-endocrine responses to psychological stress in male mice. Psychoneuroendocrinology 28(4):540\u2013558","journal-title":"Psychoneuroendocrinology"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.bbi.2012.12.011","volume":"30","author":"M Moller","year":"2013","unstructured":"Moller M et al (2013) Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine. Brain Behav Immun 30:156\u2013167","journal-title":"Brain Behav Immun"},{"issue":"5","key":"2_CR26","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3109\/10253890.2011.562939","volume":"14","author":"E Gomez-Lazaro","year":"2011","unstructured":"Gomez-Lazaro E et al (2011) Individual differences in chronically defeated male mice: behavioral, endocrine, immune, and neurotrophic changes as markers of vulnerability to the effects of stress. Stress 14(5):537\u2013548","journal-title":"Stress"},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.brainres.2013.09.033","volume":"1539","author":"G Patki","year":"2013","unstructured":"Patki G et al (2013) Depression, anxiety-like behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress. Brain Res 1539:73\u201386","journal-title":"Brain Res"},{"key":"2_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.120","volume":"2","author":"SJ Sukoff Rizzo","year":"2012","unstructured":"Sukoff Rizzo SJ et al (2012) Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes. Transl Psychiatry 2, e199","journal-title":"Transl Psychiatry"},{"issue":"6","key":"2_CR29","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.bbi.2011.03.010","volume":"25","author":"MC Audet","year":"2011","unstructured":"Audet MC et al (2011) Social defeat promotes specific cytokine variations within the prefrontal cortex upon subsequent aggressive or endotoxin challenges. Brain Behav Immun 25(6):1197\u20131205","journal-title":"Brain Behav Immun"},{"issue":"4","key":"2_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061052","volume":"8","author":"P Rinwa","year":"2013","unstructured":"Rinwa P, Kumar A, Garg S (2013) Suppression of neuroinflammatory and apoptotic signaling cascade by curcumin alone and in combination with piperine in rat model of olfactory bulbectomy induced depression. PLoS One 8(4), e61052","journal-title":"PLoS One"},{"issue":"1","key":"2_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1523\/JNEUROSCI.3569-08.2009","volume":"29","author":"C Song","year":"2009","unstructured":"Song C, Zhang XY, Manku M (2009) Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment. J Neurosci 29(1):14\u201322","journal-title":"J Neurosci"},{"issue":"2","key":"2_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.pbb.2010.08.001","volume":"97","author":"JL Ulloa","year":"2010","unstructured":"Ulloa JL et al (2010) Comparison of the antidepressant sertraline on differential depression-like behaviors elicited by restraint stress and repeated corticosterone administration. Pharmacol Biochem Behav 97(2):213\u2013221","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"2_CR33","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.neuropharm.2011.08.018","volume":"62","author":"MP Kaster","year":"2012","unstructured":"Kaster MP et al (2012) Depressive-like behavior induced by tumor necrosis factor-alpha in mice. Neuropharmacology 62(1):419\u2013426","journal-title":"Neuropharmacology"},{"issue":"1","key":"2_CR34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00004714-200202000-00014","volume":"22","author":"S Bonaccorso","year":"2002","unstructured":"Bonaccorso S et al (2002) Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol 22(1):86\u201390","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"2_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0162-3109(96)00111-7","volume":"34","author":"Z Xia","year":"1996","unstructured":"Xia Z, DePierre JW, Nassberger L (1996) Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology 34(1):27\u201337","journal-title":"Immunopharmacology"},{"issue":"6","key":"2_CR36","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1365-3083.1995.tb03604.x","volume":"41","author":"A Seidel","year":"1995","unstructured":"Seidel A et al (1995) Cytokine production and serum proteins in depression. Scand J Immunol 41(6):534\u2013538","journal-title":"Scand J Immunol"},{"issue":"6","key":"2_CR37","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1037\/0022-006X.69.6.942","volume":"69","author":"DC Mohr","year":"2001","unstructured":"Mohr DC et al (2001) Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 69(6):942\u2013949","journal-title":"J Consult Clin Psychol"},{"issue":"6","key":"2_CR38","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.intimp.2005.12.007","volume":"6","author":"D Brustolim","year":"2006","unstructured":"Brustolim D et al (2006) A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int Immunopharmacol 6(6):903\u2013907","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"2_CR39","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0893-133X(98)00088-8","volume":"20","author":"M Maes","year":"1999","unstructured":"Maes M et al (1999) Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology 20(4):370\u2013379","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"2_CR40","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0306-4530(00)00026-3","volume":"25","author":"M Kubera","year":"2000","unstructured":"Kubera M et al (2000) The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL\/6 mice. Psychoneuroendocrinology 25(8):785\u2013797","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"2_CR41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0165-1781(00)00184-0","volume":"96","author":"M Kubera","year":"2000","unstructured":"Kubera M et al (2000) Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL\/6 mice. Psychiatry Res 96(3):255\u2013266","journal-title":"Psychiatry Res"},{"issue":"7","key":"2_CR42","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.biopsych.2012.09.021","volume":"73","author":"E Beurel","year":"2013","unstructured":"Beurel E, Harrington LE, Jope RS (2013) Inflammatory T helper 17 cells promote depression-like behavior in mice. Biol Psychiatry 73(7):622\u2013630","journal-title":"Biol Psychiatry"},{"issue":"5","key":"2_CR43","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00401-015-1402-7","volume":"129","author":"A Waisman","year":"2015","unstructured":"Waisman A, Hauptmann J, Regen T (2015) The role of IL-17 in CNS diseases. Acta Neuropathol 129(5):625\u2013637","journal-title":"Acta Neuropathol"},{"issue":"3","key":"2_CR44","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1017\/S0033291712001511","volume":"43","author":"AJ Ferrari","year":"2013","unstructured":"Ferrari AJ et al (2013) Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med 43(3):471\u2013481","journal-title":"Psychol Med"},{"issue":"10","key":"2_CR45","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/oxfordjournals.aje.a009936","volume":"150","author":"EL Hurwitz","year":"1999","unstructured":"Hurwitz EL, Morgenstern H (1999) Cross-sectional associations of asthma, hay fever, and other allergies with major depression and low-back pain among adults aged 20\u201339 years in the United States. Am J Epidemiol 150(10):1107\u20131116","journal-title":"Am J Epidemiol"},{"issue":"3","key":"2_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3109\/02770903.2011.554943","volume":"48","author":"J Miguel Diez de","year":"2011","unstructured":"de Miguel Diez J et al (2011) Psychiatric comorbidity in asthma patients. Associated factors. J Asthma 48(3):253\u2013258","journal-title":"J Asthma"},{"issue":"2","key":"2_CR47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.24095\/hpcdp.30.2.03","volume":"30","author":"R Prosser","year":"2010","unstructured":"Prosser R, Carleton B, Smith A (2010) The comorbidity burden of the treated asthma patient population in British Columbia. Chronic Dis Can 30(2):46\u201355","journal-title":"Chronic Dis Can"},{"issue":"12","key":"2_CR48","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1093\/rheumatology\/ket169","volume":"52","author":"F Matcham","year":"2013","unstructured":"Matcham F et al (2013) The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 52(12):2136\u20132148","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"2_CR49","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/CRD.0b013e31820e8106","volume":"19","author":"CM Celano","year":"2011","unstructured":"Celano CM, Huffman JC (2011) Depression and cardiac disease: a review. Cardiol Rev 19(3):130\u2013142","journal-title":"Cardiol Rev"},{"issue":"10","key":"2_CR50","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/da.22387","volume":"32","author":"D Vancampfort","year":"2015","unstructured":"Vancampfort D et al (2015) Type 2 diabetes in patients with major depressive disorder: a meta-analysis of prevalence estimates and predictors. Depress Anxiety 32(10):763\u2013773","journal-title":"Depress Anxiety"},{"issue":"4","key":"2_CR51","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1023\/B:QURE.0000021694.59992.a1","volume":"13","author":"SS Ahlgren","year":"2004","unstructured":"Ahlgren SS et al (2004) Development of a preliminary diabetes dietary satisfaction and outcomes measure for patients with type 2 diabetes. Qual Life Res 13(4):819\u2013832","journal-title":"Qual Life Res"},{"issue":"6","key":"2_CR52","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1037\/0278-6133.24.6.630","volume":"24","author":"WP Sacco","year":"2005","unstructured":"Sacco WP et al (2005) Depression in adults with type 2 diabetes: the role of adherence, body mass index, and self-efficacy. Health Psychol 24(6):630\u2013634","journal-title":"Health Psychol"},{"issue":"4","key":"2_CR53","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/sj.ijo.0802204","volume":"27","author":"RE Roberts","year":"2003","unstructured":"Roberts RE et al (2003) Prospective association between obesity and depression: evidence from the Alameda County study. Int J Obes Relat Metab Disord 27(4):514\u2013521","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"5","key":"2_CR54","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.2105\/AJPH.2015.302557","volume":"105","author":"YT Nigatu","year":"2015","unstructured":"Nigatu YT et al (2015) The longitudinal joint effect of obesity and major depression on work performance impairment. Am J Public Health 105(5):e80\u2013e86","journal-title":"Am J Public Health"},{"key":"2_CR55","doi-asserted-by":"crossref","unstructured":"Zalli A et al (2015) Low-grade inflammation predicts persistence of depressive symptoms. Psychopharmacology (Berl)","DOI":"10.1007\/s00213-015-3919-9"},{"key":"2_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.8","volume":"2","author":"N Vogelzangs","year":"2012","unstructured":"Vogelzangs N et al (2012) Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl Psychiatry 2, e79","journal-title":"Transl Psychiatry"},{"key":"2_CR57","doi-asserted-by":"crossref","unstructured":"Felger JC et al (2015) Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry","DOI":"10.1038\/mp.2015.168"},{"key":"2_CR58","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000435930","volume":"30","author":"BE Leonard","year":"2015","unstructured":"Leonard BE (2015) Pain, depression and inflammation: are interconnected causative factors involved? Mod Trends Pharmacopsychiatry 30:22\u201335","journal-title":"Mod Trends Pharmacopsychiatry"},{"key":"2_CR59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jad.2014.07.032","volume":"169","author":"JJ Young","year":"2014","unstructured":"Young JJ, Bruno D, Pomara N (2014) A review of the relationship between proinflammatory cytokines and major depressive disorder. J Affect Disord 169:15\u201320","journal-title":"J Affect Disord"},{"issue":"4","key":"2_CR60","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000026615","volume":"40","author":"J Levine","year":"1999","unstructured":"Levine J et al (1999) Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 40(4):171\u2013176","journal-title":"Neuropsychobiology"},{"issue":"4","key":"2_CR61","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.biopsych.2008.08.010","volume":"65","author":"CL Raison","year":"2009","unstructured":"Raison CL et al (2009) Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry 65(4):296\u2013303","journal-title":"Biol Psychiatry"},{"issue":"1\u20132","key":"2_CR62","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jneuroim.2005.08.014","volume":"172","author":"L Pavon","year":"2006","unstructured":"Pavon L et al (2006) Th2 cytokine response in major depressive disorder patients before treatment. J Neuroimmunol 172(1\u20132):156\u2013165","journal-title":"J Neuroimmunol"},{"issue":"1\u20133","key":"2_CR63","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jad.2010.11.017","volume":"131","author":"F Euteneuer","year":"2011","unstructured":"Euteneuer F et al (2011) Depression, cytokines and experimental pain: evidence for sex-related association patterns. J Affect Disord 131(1\u20133):143\u2013149","journal-title":"J Affect Disord"},{"issue":"1","key":"2_CR64","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/S003329170500632X","volume":"36","author":"P Fitzgerald","year":"2006","unstructured":"Fitzgerald P et al (2006) Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression. Psychol Med 36(1):37\u201343","journal-title":"Psychol Med"},{"issue":"3","key":"2_CR65","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","volume":"150","author":"V Valkanova","year":"2013","unstructured":"Valkanova V, Ebmeier KP, Allan CL (2013) CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord 150(3):736\u2013744","journal-title":"J Affect Disord"},{"issue":"6","key":"2_CR66","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00228-014-1666-1","volume":"70","author":"A Gharekhani","year":"2014","unstructured":"Gharekhani A et al (2014) The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial. Eur J Clin Pharmacol 70(6):655\u2013665","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"2_CR67","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4088\/JCP.14m08986","volume":"76","author":"D Mischoulon","year":"2015","unstructured":"Mischoulon D et al (2015) A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression. J Clin Psychiatry 76(1):54\u201361","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"2_CR68","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/MJT.0000000000000078","volume":"21","author":"S Dashti-Khavidaki","year":"2014","unstructured":"Dashti-Khavidaki S et al (2014) Effects of omega-3 fatty acids on depression and quality of life in maintenance hemodialysis patients. Am J Ther 21(4):275\u2013287","journal-title":"Am J Ther"},{"issue":"11","key":"2_CR69","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1017\/S0007114511004788","volume":"107","author":"N Sinn","year":"2012","unstructured":"Sinn N et al (2012) Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. Br J Nutr 107(11):1682\u20131693","journal-title":"Br J Nutr"},{"issue":"8","key":"2_CR70","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00406-011-0191-9","volume":"261","author":"Y Tajalizadekhoob","year":"2011","unstructured":"Tajalizadekhoob Y et al (2011) The effect of low-dose omega 3 fatty acids on the treatment of mild to moderate depression in the elderly: a double-blind, randomized, placebo-controlled study. Eur Arch Psychiatry Clin Neurosci 261(8):539\u2013549","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1","key":"2_CR71","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/07315724.2010.10719817","volume":"29","author":"M Rondanelli","year":"2010","unstructured":"Rondanelli M et al (2010) Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial. J Am Coll Nutr 29(1):55\u201364","journal-title":"J Am Coll Nutr"},{"issue":"1","key":"2_CR72","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s12603-011-0011-y","volume":"15","author":"M Rondanelli","year":"2011","unstructured":"Rondanelli M et al (2011) Long chain omega 3 polyunsaturated fatty acids supplementation in the treatment of elderly depression: effects on depressive symptoms, on phospholipids fatty acids profile and on health-related quality of life. J Nutr Health Aging 15(1):37\u201344","journal-title":"J Nutr Health Aging"},{"issue":"3","key":"2_CR73","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/gme.0b013e3181f2ea2e","volume":"18","author":"MP Freeman","year":"2011","unstructured":"Freeman MP et al (2011) Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: a preliminary open trial. Menopause 18(3):279\u2013284","journal-title":"Menopause"},{"issue":"8","key":"2_CR74","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.4088\/JCP.10m05966blu","volume":"72","author":"F Lesperance","year":"2011","unstructured":"Lesperance F et al (2011) The efficacy of omega-3 supplementation for major depression: a randomized controlled trial. J Clin Psychiatry 72(8):1054\u20131062","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"2_CR75","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.4088\/JCP.08m04603","volume":"70","author":"D Mischoulon","year":"2009","unstructured":"Mischoulon D et al (2009) A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder. J Clin Psychiatry 70(12):1636\u20131644","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"2_CR76","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/ejcn.2008.81","volume":"63","author":"EH Clayton","year":"2009","unstructured":"Clayton EH et al (2009) Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. Eur J Clin Nutr 63(8):1037\u20131040","journal-title":"Eur J Clin Nutr"},{"issue":"6","key":"2_CR77","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1176\/ajp.2006.163.6.1098","volume":"163","author":"H Nemets","year":"2006","unstructured":"Nemets H et al (2006) Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry 163(6):1098\u20131100","journal-title":"Am J Psychiatry"},{"issue":"4","key":"2_CR78","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0924-977X(03)00032-4","volume":"13","author":"KP Su","year":"2003","unstructured":"Su KP et al (2003) Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 13(4):267\u2013271","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"2_CR79","first-page":"632","volume":"33","author":"LD Wiggs","year":"1991","unstructured":"Wiggs LD et al (1991) Mortality among workers exposed to external ionizing radiation at a nuclear facility in Ohio. J Occup Med 33(5):632\u2013637","journal-title":"J Occup Med"},{"issue":"1","key":"2_CR80","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1734-1140(13)70964-2","volume":"65","author":"M Haberka","year":"2013","unstructured":"Haberka M et al (2013) Effects of n-3 polyunsaturated fatty acids on depressive symptoms, anxiety and emotional state in patients with acute myocardial infarction. Pharmacol Rep 65(1):59\u201368","journal-title":"Pharmacol Rep"},{"issue":"1\u20132","key":"2_CR81","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jad.2007.12.228","volume":"110","author":"MP Freeman","year":"2008","unstructured":"Freeman MP et al (2008) Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study. J Affect Disord 110(1\u20132):142\u2013148","journal-title":"J Affect Disord"},{"issue":"1","key":"2_CR82","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/JCP.0b013e31823f3b5f","volume":"32","author":"L Gertsik","year":"2012","unstructured":"Gertsik L et al (2012) Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder. J Clin Psychopharmacol 32(1):61\u201364","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"2_CR83","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.euroneuro.2014.11.015","volume":"25","author":"AL Lopresti","year":"2015","unstructured":"Lopresti AL et al (2015) Curcumin and major depression: a randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change. Eur Neuropsychopharmacol 25(1):38\u201350","journal-title":"Eur Neuropsychopharmacol"},{"key":"2_CR84","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jad.2014.06.001","volume":"167","author":"AL Lopresti","year":"2014","unstructured":"Lopresti AL et al (2014) Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. J Affect Disord 167:368\u2013375","journal-title":"J Affect Disord"},{"key":"2_CR85","doi-asserted-by":"crossref","unstructured":"Iyengar RL et al (2013) NSAIDs are associated with lower depression scores in patients with osteoarthritis. Am J Med 126(11):1017 e11-8","DOI":"10.1016\/j.amjmed.2013.02.037"},{"issue":"4","key":"2_CR86","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/00004850-200607000-00005","volume":"21","author":"J Mendlewicz","year":"2006","unstructured":"Mendlewicz J et al (2006) Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study. Int Clin Psychopharmacol 21(4):227\u2013231","journal-title":"Int Clin Psychopharmacol"},{"issue":"7","key":"2_CR87","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/sj.mp.4001805","volume":"11","author":"N Muller","year":"2006","unstructured":"Muller N et al (2006) The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 11(7):680\u2013684","journal-title":"Mol Psychiatry"},{"issue":"2\u20133","key":"2_CR88","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jad.2012.03.033","volume":"141","author":"SH Abbasi","year":"2012","unstructured":"Abbasi SH et al (2012) Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. J Affect Disord 141(2\u20133):308\u2013314","journal-title":"J Affect Disord"},{"issue":"7","key":"2_CR89","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/da.20589","volume":"26","author":"S Akhondzadeh","year":"2009","unstructured":"Akhondzadeh S et al (2009) Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety 26(7):607\u2013611","journal-title":"Depress Anxiety"},{"issue":"2","key":"2_CR90","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/hup.912","volume":"23","author":"FG Nery","year":"2008","unstructured":"Nery FG et al (2008) Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Hum Psychopharmacol 23(2):87\u201394","journal-title":"Hum Psychopharmacol"},{"issue":"2","key":"2_CR91","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00296-010-1616-x","volume":"32","author":"I Ertenli","year":"2012","unstructured":"Ertenli I et al (2012) Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level. Rheumatol Int 32(2):323\u2013330","journal-title":"Rheumatol Int"},{"issue":"1","key":"2_CR92","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL et al (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70(1):31\u201341","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"2_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049431","volume":"7","author":"RJ Mocking","year":"2012","unstructured":"Mocking RJ et al (2012) Biological effects of add-on eicosapentaenoic acid supplementation in diabetes mellitus and co-morbid depression: a randomized controlled trial. PLoS One 7(11), e49431","journal-title":"PLoS One"},{"issue":"2\u20133","key":"2_CR94","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jad.2008.03.008","volume":"111","author":"TM Silva da","year":"2008","unstructured":"da Silva TM et al (2008) Depression in Parkinson\u2019s disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation. J Affect Disord 111(2\u20133):351\u2013359","journal-title":"J Affect Disord"},{"issue":"9","key":"2_CR95","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.euroneuro.2008.04.011","volume":"18","author":"D Mischoulon","year":"2008","unstructured":"Mischoulon D et al (2008) A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. Eur Neuropsychopharmacol 18(9):639\u2013645","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10","key":"2_CR96","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/archpsyc.59.10.913","volume":"59","author":"M Peet","year":"2002","unstructured":"Peet M, Horrobin DF (2002) A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59(10):913\u2013919","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"2_CR97","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.euroneuro.2012.08.003","volume":"23","author":"H Mozaffari-Khosravi","year":"2013","unstructured":"Mozaffari-Khosravi H et al (2013) Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 23(7):636\u2013644","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"2_CR98","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/WNF.0b013e31828ef969","volume":"36","author":"J Bergman","year":"2013","unstructured":"Bergman J et al (2013) Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study. Clin Neuropharmacol 36(3):73\u201377","journal-title":"Clin Neuropharmacol"},{"issue":"9","key":"2_CR99","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s11745-013-3801-7","volume":"48","author":"BJ Meyer","year":"2013","unstructured":"Meyer BJ et al (2013) Improvement of major depression is associated with increased erythrocyte DHA. Lipids 48(9):863\u2013868","journal-title":"Lipids"},{"issue":"5","key":"2_CR100","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1177\/0269881111424928","volume":"26","author":"N Antypa","year":"2012","unstructured":"Antypa N et al (2012) Effects of omega-3 fatty acid supplementation on mood and emotional information processing in recovered depressed individuals. J Psychopharmacol 26(5):738\u2013743","journal-title":"J Psychopharmacol"},{"issue":"6","key":"2_CR101","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.3945\/ajcn.111.018259","volume":"94","author":"EJ Giltay","year":"2011","unstructured":"Giltay EJ, Geleijnse JM, Kromhout D (2011) Effects of n-3 fatty acids on depressive symptoms and dispositional optimism after myocardial infarction. Am J Clin Nutr 94(6):1442\u20131450","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"2_CR102","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/00048670701827267","volume":"42","author":"AM Rees","year":"2008","unstructured":"Rees AM, Austin MP, Parker GB (2008) Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial. Aust N Z J Psychiatry 42(3):199\u2013205","journal-title":"Aust N Z J Psychiatry"},{"issue":"7","key":"2_CR103","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.pnpbp.2007.06.004","volume":"31","author":"BF Grenyer","year":"2007","unstructured":"Grenyer BF et al (2007) Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 31(7):1393\u20131396","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"2_CR104","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1600-0447.2005.00660.x","volume":"113","author":"MP Freeman","year":"2006","unstructured":"Freeman MP et al (2006) Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand 113(1):31\u201335","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"2_CR105","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1067\/mob.2003.275","volume":"188","author":"AM Llorente","year":"2003","unstructured":"Llorente AM et al (2003) Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am J Obstet Gynecol 188(5):1348\u20131353","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2_CR106","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1176\/appi.ajp.160.5.996","volume":"160","author":"LB Marangell","year":"2003","unstructured":"Marangell LB et al (2003) A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 160(5):996\u2013998","journal-title":"Am J Psychiatry"},{"issue":"2","key":"2_CR107","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3945\/ajcn.2008.26749","volume":"89","author":"M Lucas","year":"2009","unstructured":"Lucas M et al (2009) Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial. Am J Clin Nutr 89(2):641\u2013651","journal-title":"Am J Clin Nutr"},{"issue":"1\u20132","key":"2_CR108","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jad.2010.04.008","volume":"126","author":"M Bot","year":"2010","unstructured":"Bot M et al (2010) Eicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus: a randomized, double-blind placebo-controlled study. J Affect Disord 126(1\u20132):282\u2013286","journal-title":"J Affect Disord"},{"issue":"3","key":"2_CR109","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.plefa.2004.11.004","volume":"72","author":"KM Silvers","year":"2005","unstructured":"Silvers KM et al (2005) Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins Leukot Essent Fatty Acids 72(3):211\u2013218","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"9","key":"2_CR110","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.biopsych.2006.03.056","volume":"60","author":"PE Keck Jr","year":"2006","unstructured":"Keck PE Jr et al (2006) Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry 60(9):1020\u20131022","journal-title":"Biol Psychiatry"},{"issue":"4","key":"2_CR111","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000321804","volume":"63","author":"M Bot","year":"2011","unstructured":"Bot M et al (2011) Supplementation with eicosapentaenoic omega-3 fatty acid does not influence serum brain-derived neurotrophic factor in diabetes mellitus patients with major depression: a randomized controlled pilot study. Neuropsychobiology 63(4):219\u2013223","journal-title":"Neuropsychobiology"},{"issue":"15","key":"2_CR112","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1001\/jama.2009.1487","volume":"302","author":"RM Carney","year":"2009","unstructured":"Carney RM et al (2009) Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA 302(15):1651\u20131657","journal-title":"JAMA"},{"issue":"1","key":"2_CR113","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jpsychores.2010.11.006","volume":"71","author":"M Bot","year":"2011","unstructured":"Bot M et al (2011) Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression. J Psychosom Res 71(1):13\u201317","journal-title":"J Psychosom Res"},{"issue":"4","key":"2_CR114","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/ptr.5025","volume":"28","author":"J Sanmukhani","year":"2014","unstructured":"Sanmukhani J et al (2014) Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytother Res 28(4):579\u2013585","journal-title":"Phytother Res"},{"issue":"6","key":"2_CR115","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/JGP.0b013e318227f4da","volume":"20","author":"C Fields","year":"2012","unstructured":"Fields C et al (2012) Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older: findings from a randomized controlled trial. Am J Geriatr Psychiatry 20(6):505\u2013513","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"2_CR116","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1515\/rns.2011.030","volume":"22","author":"CF Sharpley","year":"2011","unstructured":"Sharpley CF, Agnew LL (2011) Cytokines and depression: findings, issues, and treatment implications. Rev Neurosci 22(3):295\u2013302","journal-title":"Rev Neurosci"},{"issue":"6","key":"2_CR117","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","volume":"87","author":"CA Dinarello","year":"1996","unstructured":"Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87(6):2095\u20132147","journal-title":"Blood"},{"issue":"5","key":"2_CR118","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/(SICI)1097-4547(19970901)49:5<541::AID-JNR4>3.0.CO;2-B","volume":"49","author":"CR Plata-Salaman","year":"1997","unstructured":"Plata-Salaman CR, Ilyin SE (1997) Interleukin-1beta (IL-1beta)-induced modulation of the hypothalamic IL-1beta system, tumor necrosis factor-alpha, and transforming growth factor-beta1 mRNAs in obese (fa\/fa) and lean (Fa\/Fa) Zucker rats: implications to IL-1beta feedback systems and cytokine-cytokine interactions. J Neurosci Res 49(5):541\u2013550","journal-title":"J Neurosci Res"},{"issue":"3","key":"2_CR119","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/1534735410370036","volume":"9","author":"CF Jehn","year":"2010","unstructured":"Jehn CF et al (2010) Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer. Integr Cancer Ther 9(3):270\u2013275","journal-title":"Integr Cancer Ther"},{"issue":"6","key":"2_CR120","first-page":"1690","volume":"77","author":"G Mastorakos","year":"1993","unstructured":"Mastorakos G, Chrousos GP, Weber JS (1993) Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 77(6):1690\u20131694","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2_CR121","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.biopsych.2006.03.075","volume":"60","author":"H Himmerich","year":"2006","unstructured":"Himmerich H et al (2006) Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis. Biol Psychiatry 60(8):882\u2013888","journal-title":"Biol Psychiatry"},{"issue":"5\u20136","key":"2_CR122","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0306-9877(03)00207-X","volume":"61","author":"AM Myint","year":"2003","unstructured":"Myint AM, Kim YK (2003) Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 61(5\u20136):519\u2013525","journal-title":"Med Hypotheses"},{"issue":"5","key":"2_CR123","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2174\/13894501113149990154","volume":"14","author":"M Catena-Dell'Osso","year":"2013","unstructured":"Catena-Dell'Osso M et al (2013) Inflammation, serotonin and major depression. Curr Drug Targets 14(5):571\u2013577","journal-title":"Curr Drug Targets"},{"issue":"10","key":"2_CR124","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/jir.1997.17.589","volume":"17","author":"LA Pemberton","year":"1997","unstructured":"Pemberton LA et al (1997) Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha. J Interferon Cytokine Res 17(10):589\u2013595","journal-title":"J Interferon Cytokine Res"},{"issue":"1\u20132","key":"2_CR125","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/0006-8993(94)90006-X","volume":"643","author":"S Zalcman","year":"1994","unstructured":"Zalcman S et al (1994) Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res 643(1\u20132):40\u201349","journal-title":"Brain Res"},{"issue":"6 Pt 1","key":"2_CR126","first-page":"G1123","volume":"266","author":"SM Hurst","year":"1994","unstructured":"Hurst SM, Collins SM (1994) Mechanism underlying tumor necrosis factor-alpha suppression of norepinephrine release from rat myenteric plexus. Am J Physiol 266(6 Pt 1):G1123\u2013G1129","journal-title":"Am J Physiol"},{"issue":"5","key":"2_CR127","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1159\/000026391","volume":"6","author":"T Ando","year":"1999","unstructured":"Ando T, Dunn AJ (1999) Mouse tumor necrosis factor-alpha increases brain tryptophan concentrations and norepinephrine metabolism while activating the HPA axis in mice. Neuroimmunomodulation 6(5):319\u2013329","journal-title":"Neuroimmunomodulation"},{"issue":"24","key":"2_CR128","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1523\/JNEUROSCI.23-24-08480.2003","volume":"23","author":"JA Moron","year":"2003","unstructured":"Moron JA et al (2003) Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J Neurosci 23(24):8480\u20138488","journal-title":"J Neurosci"},{"issue":"1","key":"2_CR129","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00702-006-0562-y","volume":"114","author":"HQ Wu","year":"2007","unstructured":"Wu HQ, Rassoulpour A, Schwarcz R (2007) Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain? J Neural Transm (Vienna) 114(1):33\u201341","journal-title":"J Neural Transm (Vienna)"},{"issue":"2","key":"2_CR130","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0006-8993(96)01371-6","volume":"747","author":"H Shuto","year":"1997","unstructured":"Shuto H et al (1997) Repeated interferon-alpha administration inhibits dopaminergic neural activity in the mouse brain. Brain Res 747(2):348\u2013351","journal-title":"Brain Res"},{"issue":"1\u20132","key":"2_CR131","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0006-8993(03)02776-8","volume":"978","author":"T Kitagami","year":"2003","unstructured":"Kitagami T et al (2003) Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: role of nitric oxide as a signal crossing the blood\u2013brain barrier. Brain Res 978(1\u20132):104\u2013114","journal-title":"Brain Res"},{"issue":"25","key":"2_CR132","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1523\/JNEUROSCI.23-25-08692.2003","volume":"23","author":"B Viviani","year":"2003","unstructured":"Viviani B et al (2003) Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 23(25):8692\u20138700","journal-title":"J Neurosci"},{"issue":"3","key":"2_CR133","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000026433","volume":"7","author":"S Hu","year":"2000","unstructured":"Hu S et al (2000) Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 7(3):153\u2013159","journal-title":"Neuroimmunomodulation"},{"issue":"3","key":"2_CR134","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.neuroscience.2005.03.051","volume":"135","author":"S Hayley","year":"2005","unstructured":"Hayley S et al (2005) The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 135(3):659\u2013678","journal-title":"Neuroscience"},{"issue":"12","key":"2_CR135","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1038\/sj.npp.1301137","volume":"31","author":"N Kaneko","year":"2006","unstructured":"Kaneko N et al (2006) Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus. Neuropsychopharmacology 31(12):2619\u20132626","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"2_CR136","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R et al (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9(1):46\u201356","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2_CR137","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","volume":"27","author":"CL Raison","year":"2006","unstructured":"Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27(1):24\u201331","journal-title":"Trends Immunol"},{"issue":"5","key":"2_CR138","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1212\/WNL.45.5.947","volume":"45","author":"MA Pavol","year":"1995","unstructured":"Pavol MA et al (1995) Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia. Neurology 45(5):947\u2013950","journal-title":"Neurology"},{"issue":"2","key":"2_CR139","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000026485","volume":"37","author":"M Malaguarnera","year":"1998","unstructured":"Malaguarnera M et al (1998) Interferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alpha. Neuropsychobiology 37(2):93\u201397","journal-title":"Neuropsychobiology"},{"issue":"3","key":"2_CR140","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<482::AID-CNCR17>3.0.CO;2-S","volume":"83","author":"A Caraceni","year":"1998","unstructured":"Caraceni A et al (1998) Neurotoxicity of interferon-alpha in melanoma therapy: results from a randomized controlled trial. Cancer 83(3):482\u2013489","journal-title":"Cancer"},{"issue":"4","key":"2_CR141","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/mp.2009.116","volume":"15","author":"CL Raison","year":"2010","unstructured":"Raison CL et al (2010) CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry 15(4):393\u2013403","journal-title":"Mol Psychiatry"},{"issue":"4","key":"2_CR142","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0278-5846(01)00324-4","volume":"26","author":"M Schaefer","year":"2002","unstructured":"Schaefer M et al (2002) Interferon alpha (IFNalpha) and psychiatric syndromes: a review. Prog Neuropsychopharmacol Biol Psychiatry 26(4):731\u2013746","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"2_CR143","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.bbi.2008.09.007","volume":"23","author":"L Brydon","year":"2009","unstructured":"Brydon L et al (2009) Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans. Brain Behav Immun 23(2):217\u2013224","journal-title":"Brain Behav Immun"},{"issue":"2","key":"2_CR144","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0022-3999(03)00569-5","volume":"57","author":"PC Strike","year":"2004","unstructured":"Strike PC, Wardle J, Steptoe A (2004) Mild acute inflammatory stimulation induces transient negative mood. J Psychosom Res 57(2):189\u2013194","journal-title":"J Psychosom Res"},{"issue":"3","key":"2_CR145","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0009-8981(56)90068-7","volume":"1","author":"F Geubelle","year":"1956","unstructured":"Geubelle F (1956) Spectrophotometric semi-micro method for the determination of the hemoglobin-oxyhemoglobin ratio in the blood. Clin Chim Acta 1(3):225\u2013228","journal-title":"Clin Chim Acta"},{"issue":"5","key":"2_CR146","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y et al (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67(5):446\u2013457","journal-title":"Biol Psychiatry"},{"issue":"3","key":"2_CR147","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1001\/jamapsychiatry.2014.2427","volume":"72","author":"E Setiawan","year":"2015","unstructured":"Setiawan E et al (2015) Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 72(3):268\u2013275","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"2_CR148","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000119472","volume":"24","author":"M Maes","year":"1990","unstructured":"Maes M et al (1990) Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. Neuropsychobiology 24(3):115\u2013120","journal-title":"Neuropsychobiology"},{"issue":"1","key":"2_CR149","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pnpbp.2011.09.006","volume":"36","author":"M Maes","year":"2012","unstructured":"Maes M et al (2012) Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression. Prog Neuropsychopharmacol Biol Psychiatry 36(1):169\u2013175","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"2_CR150","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0165-1781(93)90102-M","volume":"49","author":"M Maes","year":"1993","unstructured":"Maes M et al (1993) Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression. Psychiatry Res 49(2):151\u2013165","journal-title":"Psychiatry Res"},{"issue":"8","key":"2_CR151","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/j.1469-7610.2010.02245.x","volume":"51","author":"V Gabbay","year":"2010","unstructured":"Gabbay V et al (2010) The possible role of the kynurenine pathway in adolescent depression with melancholic features. J Child Psychol Psychiatry 51(8):935\u2013943","journal-title":"J Child Psychol Psychiatry"},{"issue":"3","key":"2_CR152","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M et al (2011) The new \u20185-HT\u2019 hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry 35(3):702\u2013721","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2_CR153","doi-asserted-by":"crossref","unstructured":"Tang CZ et al (2015) Elevated serum levels of neopterin at admission predicts depression after acute ischemic stroke: a 6-month follow-up study. Mol Neurobiol","DOI":"10.1007\/s12035-015-9220-4"},{"issue":"10","key":"2_CR154","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1039\/c2mb25118c","volume":"8","author":"AC Andreazza","year":"2012","unstructured":"Andreazza AC (2012) Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders. Mol Biosyst 8(10):2503\u20132512","journal-title":"Mol Biosyst"},{"issue":"10","key":"2_CR155","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138904","volume":"10","author":"T Liu","year":"2015","unstructured":"Liu T et al (2015) A meta-analysis of oxidative stress markers in depression. PLoS One 10(10), e0138904","journal-title":"PLoS One"},{"key":"2_CR156","first-page":"2479","volume":"11","author":"G Mazereeuw","year":"2015","unstructured":"Mazereeuw G et al (2015) A meta-analysis of lipid peroxidation markers in major depression. Neuropsychiatr Dis Treat 11:2479\u20132491","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2_CR157","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.psyneuen.2014.09.025","volume":"51","author":"CN Black","year":"2015","unstructured":"Black CN et al (2015) Is depression associated with increased oxidative stress? A systematic review and meta-analysis. Psychoneuroendocrinology 51:164\u2013175","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"2_CR158","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10787-011-0111-7","volume":"20","author":"M Maes","year":"2012","unstructured":"Maes M et al (2012) New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates\u2014Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology 20(3):127\u2013150","journal-title":"Inflammopharmacology"},{"issue":"4","key":"2_CR159","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/07853890801923753","volume":"40","author":"L Shao","year":"2008","unstructured":"Shao L et al (2008) Mitochondrial involvement in psychiatric disorders. Ann Med 40(4):281\u2013295","journal-title":"Ann Med"},{"issue":"1","key":"2_CR160","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1172\/JCI115856","volume":"90","author":"A Suomalainen","year":"1992","unstructured":"Suomalainen A et al (1992) Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Invest 90(1):61\u201366","journal-title":"J Clin Invest"},{"issue":"2","key":"2_CR161","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000112891","volume":"77","author":"A Gardner","year":"2008","unstructured":"Gardner A, Boles RG (2008) Mitochondrial energy depletion in depression with somatization. Psychother Psychosom 77(2):127\u2013129","journal-title":"Psychother Psychosom"},{"issue":"5","key":"2_CR162","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125855","volume":"10","author":"CC Chang","year":"2015","unstructured":"Chang CC et al (2015) Mitochondria DNA change and oxidative damage in clinically stable patients with major depressive disorder. PLoS One 10(5), e0125855","journal-title":"PLoS One"},{"key":"2_CR163","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1471-2164-9-144","volume":"9","author":"W Rodenburg","year":"2008","unstructured":"Rodenburg W et al (2008) Impaired barrier function by dietary fructo-oligosaccharides (FOS) in rats is accompanied by increased colonic mitochondrial gene expression. BMC Genomics 9:144","journal-title":"BMC Genomics"},{"issue":"2","key":"2_CR164","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.neubiorev.2011.12.005","volume":"36","author":"B Leonard","year":"2012","unstructured":"Leonard B, Maes M (2012) Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 36(2):764\u2013785","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"2_CR165","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","volume":"139","author":"Y Liu","year":"2012","unstructured":"Liu Y, Ho RC, Mak A (2012) Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord 139(3):230\u2013239","journal-title":"J Affect Disord"},{"issue":"2","key":"2_CR166","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1017\/S1092852915000449","volume":"21","author":"M Martin-Subero","year":"2016","unstructured":"Martin-Subero M et al (2016) Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways. CNS Spectr 21(2):184\u2013198","journal-title":"CNS Spectr"},{"issue":"8","key":"2_CR167","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.neubiorev.2013.06.010","volume":"37","author":"G Mazereeuw","year":"2013","unstructured":"Mazereeuw G et al (2013) Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegeneration. Neurosci Biobehav Rev 37(8):1611\u20131621","journal-title":"Neurosci Biobehav Rev"},{"key":"2_CR168","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.2741\/2759","volume":"13","author":"RM Adibhatla","year":"2008","unstructured":"Adibhatla RM, Dempsy R, Hatcher JF (2008) Integration of cytokine biology and lipid metabolism in stroke. Front Biosci 13:1250\u20131270","journal-title":"Front Biosci"},{"issue":"11","key":"2_CR169","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.bbalip.2006.08.001","volume":"1761","author":"Y Kita","year":"2006","unstructured":"Kita Y et al (2006) Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s. Biochim Biophys Acta 1761(11):1317\u20131322","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"2_CR170","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/0091-6749(92)90104-A","volume":"90","author":"M Thivierge","year":"1992","unstructured":"Thivierge M, Rola-Pleszczynski M (1992) Platelet-activating factor enhances interleukin-6 production by alveolar macrophages. J Allergy Clin Immunol 90(5):796\u2013802","journal-title":"J Allergy Clin Immunol"},{"issue":"1\u20133","key":"2_CR171","first-page":"175","volume":"6","author":"M Rola-Pleszczynski","year":"1993","unstructured":"Rola-Pleszczynski M et al (1993) Differential regulation of cytokine and cytokine receptor genes by PAF, LTB4 and PGE2. J Lipid Mediat 6(1\u20133):175\u2013181","journal-title":"J Lipid Mediat"},{"key":"2_CR172","first-page":"2309","volume":"11","author":"G Mazereeuw","year":"2015","unstructured":"Mazereeuw G et al (2015) Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study. Neuropsychiatr Dis Treat 11:2309\u20132314","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"3","key":"2_CR173","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.cell.2015.10.001","volume":"163","author":"GS Shadel","year":"2015","unstructured":"Shadel GS, Horvath TL (2015) Mitochondrial ROS signaling in organismal homeostasis. Cell 163(3):560\u2013569","journal-title":"Cell"},{"key":"2_CR174","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neubiorev.2014.05.007","volume":"45","author":"S Moylan","year":"2014","unstructured":"Moylan S et al (2014) Oxidative & nitrosative stress in depression: why so much stress? Neurosci Biobehav Rev 45:46\u201362","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"2_CR175","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.pnpbp.2010.05.004","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M et al (2011) A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry 35(3):676\u2013692","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1\u20133","key":"2_CR176","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jad.2012.06.039","volume":"149","author":"M Maes","year":"2013","unstructured":"Maes M et al (2013) Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression. J Affect Disord 149(1\u20133):23\u201329","journal-title":"J Affect Disord"},{"issue":"1\u20133","key":"2_CR177","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jad.2011.08.023","volume":"135","author":"M Maes","year":"2011","unstructured":"Maes M et al (2011) IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology. J Affect Disord 135(1\u20133):414\u2013418","journal-title":"J Affect Disord"},{"issue":"3","key":"2_CR178","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.pharep.2014.12.014","volume":"67","author":"A Moniczewski","year":"2015","unstructured":"Moniczewski A et al (2015) Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 1. Chemical aspects and biological sources of oxidative stress in the brain. Pharmacol Rep 67(3):560\u2013568","journal-title":"Pharmacol Rep"},{"key":"2_CR179","volume-title":"Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: results from a meta-analysis","author":"S Jimenez-Fernandez","year":"2015","unstructured":"Jimenez-Fernandez S et al (2015) Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: results from a meta-analysis., J Clin Psychiatry"},{"key":"2_CR180","doi-asserted-by":"publisher","first-page":"898393","DOI":"10.1155\/2015\/898393","volume":"2015","author":"M Vavakova","year":"2015","unstructured":"Vavakova M, Durackova Z, Trebaticka J (2015) Markers of oxidative stress and neuroprogression in depression disorder. Oxid Med Cell Longev 2015:898393","journal-title":"Oxid Med Cell Longev"},{"key":"2_CR181","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fcell.2015.00062","volume":"3","author":"EA Novak","year":"2015","unstructured":"Novak EA, Mollen KP (2015) Mitochondrial dysfunction in inflammatory bowel disease. Front Cell Dev Biol 3:62","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"2_CR182","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.pnpbp.2005.03.008","volume":"29","author":"R Garza De La 2nd","year":"2005","unstructured":"De La Garza R 2nd et al (2005) Recombinant human interferon-alpha does not alter reward behavior, or neuroimmune and neuroendocrine activation in rats. Prog Neuropsychopharmacol Biol Psychiatry 29(5):781\u2013792","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1\u20132","key":"2_CR183","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jpsychires.2005.11.003","volume":"41","author":"AH Marques-Deak","year":"2007","unstructured":"Marques-Deak AH et al (2007) Cytokine profiles in women with different subtypes of major depressive disorder. J Psychiatr Res 41(1\u20132):152\u2013159","journal-title":"J Psychiatr Res"},{"issue":"4","key":"2_CR184","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1017\/S0033291702007250","volume":"33","author":"A Steptoe","year":"2003","unstructured":"Steptoe A, Kunz-Ebrecht SR, Owen N (2003) Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol Med 33(4):667\u2013674","journal-title":"Psychol Med"},{"issue":"3","key":"2_CR185","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0304-3940(98)00916-1","volume":"259","author":"S Stubner","year":"1999","unstructured":"Stubner S et al (1999) Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130. Neurosci Lett 259(3):145\u2013148","journal-title":"Neurosci Lett"},{"issue":"4","key":"2_CR186","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1600-0447.1998.tb10005.x","volume":"97","author":"F Brambilla","year":"1998","unstructured":"Brambilla F, Maggioni M (1998) Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatr Scand 97(4):309\u2013313","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"2_CR187","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jpsychores.2007.05.013","volume":"63","author":"FE Lotrich","year":"2007","unstructured":"Lotrich FE et al (2007) Depression following pegylated interferon-alpha: characteristics and vulnerability. J Psychosom Res 63(2):131\u2013135","journal-title":"J Psychosom Res"},{"issue":"3","key":"2_CR188","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jad.2012.08.007","volume":"145","author":"M Fornaro","year":"2013","unstructured":"Fornaro M et al (2013) Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds. J Affect Disord 145(3):300\u2013307","journal-title":"J Affect Disord"},{"issue":"1","key":"2_CR189","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.watres.2012.09.048","volume":"47","author":"JC Baudez","year":"2013","unstructured":"Baudez JC et al (2013) The viscoelastic behaviour of raw and anaerobic digested sludge: strong similarities with soft-glassy materials. Water Res 47(1):173\u2013180","journal-title":"Water Res"}],"container-title":["Current Topics in Behavioral Neurosciences","Inflammation-Associated Depression: Evidence, Mechanisms and Implications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2016_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T08:35:46Z","timestamp":1656578146000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/7854_2016_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319511511","9783319511528"],"references-count":189,"URL":"https:\/\/doi.org\/10.1007\/7854_2016_2","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"25 May 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}